These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. De novo Donor-specific Anti-human Leukocyte Antigen Antibody and Its Outcome in Pediatric Renal Transplant Recipients: A Single-center Experience in India. Saha A, Kapadia SF, Vala KB, Trivedi VB, Patel HV, Shah PR, Kute VB. Saudi J Kidney Dis Transpl; 2023 Jan 01; 34(1):87-95. PubMed ID: 38092720 [Abstract] [Full Text] [Related]
37. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, López AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernández-Viña M, Champlin RE, Cao K. Biol Blood Marrow Transplant; 2015 Aug 01; 21(8):1392-8. PubMed ID: 25985919 [Abstract] [Full Text] [Related]
38. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch. Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D. Transplantation; 2011 Oct 27; 92(8):900-6. PubMed ID: 21968524 [Abstract] [Full Text] [Related]
39. Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival. Redondo-Pachón D, Pascual J, Pérez-Sáez MJ, García C, Hernández JJ, Gimeno J, Mir M, Crespo M. Transpl Immunol; 2016 Feb 27; 34():1-7. PubMed ID: 26603314 [Abstract] [Full Text] [Related]
40. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Abu-Elmagd KM, Wu G, Costa G, Lunz J, Martin L, Koritsky DA, Murase N, Irish W, Zeevi A. Am J Transplant; 2012 Nov 27; 12(11):3047-60. PubMed ID: 22947059 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]